IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice

Journal of Immunology

Volumn 185, Issue 9, 2010, Pages 5619-5627

  Chen, Shuang ^a,b   Shimada, Kenichi ^a,b   Zhang, Wenxuan ^a,b   Huang, Ganghua ^a,b   Crother, Timothy R ^a,b   Arditi, Moshe ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GAMMA INTERFERON; INTERLEUKIN 12P40; INTERLEUKIN 17; MONOCYTE CHEMOTACTIC PROTEIN 1; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA SINUS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; C57BL 6 MOUSE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CYTOKINE RELEASE; DISEASE EXACERBATION; ENDOTHELIUM; FOAM CELL; IN VITRO STUDY; LIPID COMPOSITION; LIPID DIET; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; AORTA; ATHEROGENIC DIET; BIOSYNTHESIS; C57BL MOUSE; CELL SEPARATION; CHLAMYDOPHILA INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; AORTA; ATHEROSCLEROSIS; CELL SEPARATION; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOKINES; DIET, ATHEROGENIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 78149490050     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001879     Document Type: Article

References (68)

1. Hansson, G. K., P. Libby, U. Schönbeck, and Z. Q. Yan. 2002. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91:281-291.
2. Coffman, R. L. 2006. Origins of the T (H) 1-T (H) 2 model: a personal perspective. Nat. Immunol. 7:539-541.
3. Moseley, T. A., D. R. Haudenschild, L. Rose, and A. H. Reddi. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155-174.
4. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25:821-852.
5. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21:467-476.
6. Lubberts, E. 2008. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine 41:84-91.
7. Lubberts, E., M. I. Koenders, and W. B. van den Berg. 2005. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther. 7:29-37.
8. Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. Ito, T. Nakamura, et al. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204:2803-2812.
9. Atarashi, K., J. Nishimura, T. Shima, Y. Umesaki, M. Yamamoto, M. Onoue, H. Yagita, N. Ishii, R. Evans, K. Honda, and K. Takeda. 2008. ATP drives lamina propria T (H) 17 cell differentiation. Nature 455:808-812.
10. Ivanov, I. I., Rde. L. Frutos, N. Manel, K. Yoshinaga, D. B. Rifkin, R. B. Sartor, B. B. Finlay, and D. R. Littman. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337-349.
11. Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65-70.
12. Yang, X. O., S. H. Chang, H. Park, R. Nurieva, B. Shah, L. Acero, Y. H. Wang, K. S. Schluns, R. R. Broaddus, Z. Zhu, and C. Dong. 2008. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205:1063-1075.
13. Elson, C. O., Y. Cong, C. T. Weaver, T. R. Schoeb, T. K. McClanahan, R. B. Fick, and R. A. Kastelein. 2007. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132:2359-2370.
14. Wakashin, H., K. Hirose, Y. Maezawa, S. Kagami, A. Suto, N. Watanabe, Y. Saito, M. Hatano, T. Tokuhisa, Y. Iwakura, et al. 2008. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 178:1023-1032.
15. Tesmer, L. A., S. K. Lundy, S. Sarkar, and D. A. Fox. 2008. Th17 cells in human disease. Immunol. Rev. 223:87-113.
16. Lin, Y., S. Ritchea, A. Logar, S. Slight, M. Messmer, J. Rangel-Moreno, L. Guglani, J. F. Alcorn, H. Strawbridge, S. M. Park, et al. 2009. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31:799-810.
17. O'Connor, W., Jr., L. A. Zenewicz, and R. A. Flavell. 2010. The dual nature of T (H) 17 cells: shifting the focus to function. Nat. Immunol. 11:471-476.
18. Song, L., and C. Schindler. 2004. IL-6 and the acute phase response in murine atherosclerosis. Atherosclerosis 177:43-51.
19. Eid, R. E., D. A. Rao, J. Zhou, S. F. Lo, H. Ranjbaran, A. Gallo, S. I. Sokol, S. Pfau, J. S. Pober, and G. Tellides. 2009. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 119:1424-1432.
20. Cheng, X., X. Yu, Y. J. Ding, Q. Q. Fu, J. J. Xie, T. T. Tang, R. Yao, Y. Chen, and Y. H. Liao. 2008. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 127:89-97.
21. van Es, T., G. H. van Puijvelde, O. H. Ramos, F. M. Segers, L. A. Joosten, W. B. van den Berg, I. M. Michon, P. de Vos, T. J. van Berkel, and J. Kuiper. 2009. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem. Biophys. Res. Commun. 388:261-265.
22. Erbel, C., L. Chen, F. Bea, S. Wangler, S. Celik, F. Lasitschka, Y. Wang, D. Böckler, H. A. Katus, and T. J. Dengler. 2009. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J. Immunol. 183:8167-8175.
23. Smith, E., K. M. Prasad, M. Butcher, A. Dobrian, J. K. Kolls, K. Ley, and E. Galkina. 2010. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121:1746-1755.
24. Taleb, S., M. Romain, B. Ramkhelawon, C. Uyttenhove, G. Pasterkamp, O. Herbin, B. Esposito, N. Perez, H. Yasukawa, J. Van Snick, et al. 2009. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 206:2067-2077.
25. Naiki, Y., R. Sorrentino, M. H. Wong, K. S. Michelsen, K. Shimada, S. Chen, A. Yilmaz, A. Slepenkin, N. W. Schröder, T. R. Crother, et al. 2008. TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J. Immunol. 181:7176-7185.
26. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375-387.
27. Michelsen, K. S., M. H. Wong, P. K. Shah, W. Zhang, J. Yano, T. M. Doherty, S. Akira, T. B. Rajavashisth, and M. Arditi. 2004. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA 101:10679-10684.
28. Blessing, E., L. A. Campbell, M. E. Rosenfeld, N. Chough, and C. C. Kuo. 2001. Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 158:13-17.
29. de Haan, J. B., P. K. Witting, N. Stefanovic, J. Pete, M. Daskalakis, I. Kola, R. Stocker, and J. J. Smolich. 2006. Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet. J. Lipid Res. 47:1157-1167.
30. Getz, G. S., and C. A. Reardon. 2006. Diet and murine atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26:242-249.
31. Nishina, P. M., S. Lowe, J. Verstuyft, J. K. Naggert, F. A. Kuypers, and B. Paigen. 1993. Effects of dietary fats from animal and plant sources on dietinduced fatty streak lesions in C57BL/6J mice. J. Lipid Res. 34:1413-1422.
32. Qiao, J. H., J. Tripathi, N. K. Mishra, Y. Cai, S. Tripathi, X. P. Wang, S. Imes, M. C. Fishbein, S. K. Clinton, P. Libby, et al. 1997. Role of macrophage colonystimulating factor in atherosclerosis: studies of osteopetrotic mice. Am. J. Pathol. 150:1687-1699.
33. Chen, S., R. Sorrentino, K. Shimada, Y. Bulut, T. M. Doherty, T. R. Crother, and M. Arditi. 2008. Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and-independent signaling and is reciprocally modulated by liver X receptor activation. J. Immunol. 181:7186-7193.
34. Moazed, T. C., L. A. Campbell, M. E. Rosenfeld, J. T. Grayston, and C. C. Kuo. 1999. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J. Infect. Dis. 180:238-241.
35. Bai, H., J. Cheng, X. Gao, A. G. Joyee, Y. Fan, S. Wang, L. Jiao, Z. Yao, and X. Yang. 2009. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J. Immunol. 183:5886-5895.
36. Zhou, X., Q. Chen, J. Moore, J. K. Kolls, S. Halperin, and J. Wang. 2009. Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species. Infect. Immun. 77:5059-5070.
37. Zhang, X., L. Gao, L. Lei, Y. Zhong, P. Dube, M. T. Berton, B. Arulanandam, J. Zhang, and G. Zhong. 2009. A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum. J. Immunol. 183:1291-1300.
38. Roussel, L., F. Houle, C. Chan, Y. Yao, J. Bérubé, R. Olivenstein, J. G. Martin, J. Huot, Q. Hamid, L. Ferri, and S. Rousseau. 2010. IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J. Immunol. 184:4531-4537.
39. Agache, I., C. Ciobanu, C. Agache, and M. Anghel. 2010. Increased serum IL-17 is an independent risk factor for severe asthma. Respir. Med. 104:1131-1137.
40. Lafdil, F., A. M. Miller, S. H. Ki, and B. Gao. 2010. Th17 cells and their associated cytokines in liver diseases. Cell. Mol. Immunol. 7:250-254.
41. Sarra, M., F. Pallone, T. T. Macdonald, and G. Monteleone. 2010. IL-23/IL-17 axis in IBD. Inflamm. Bowel Dis. DOI: 10.1002/ibd.21248.
42. Algood, H. M., S. S. Allen, M. K. Washington, R. M. Peek, Jr., G. G. Miller, and T. L. Cover. 2009. Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection. J. Immunol. 183:5837-5846.
43. Rothstein, N. M., T. C. Quinn, G. Madico, C. A. Gaydos, and C. J. Lowenstein. 2001. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J. Infect. Dis. 183:232-238.
44. Ishida, B. Y., D. Albee, and B. Paigen. 1990. Interconversion of prebetamigrating lipoproteins containing apolipoprotein A-I and HDL. J. Lipid Res. 31:227-236.
45. Paigen, B. 1995. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am. J. Clin. Nutr. 62:458S-462S.
46. Ishida, B. Y., P. J. Blanche, A. V. Nichols, M. Yashar, and B. Paigen. 1991. Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL/6 and C3H. J. Lipid Res. 32:559-568.
47. Chesebro, B. B., E. Blessing, C. C. Kuo, M. E. Rosenfeld, M. Puolakkainen, and L. A. Campbell. 2003. Nitric oxide synthase plays a role in Chlamydia pneumoniae-induced atherosclerosis. Cardiovasc. Res. 60:170-174.
48. Hu, H., G. N. Pierce, and G. Zhong. 1999. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Invest. 103:747-753.
49. Saitoh, T., T. Kusunoki, T. Yao, K. Kawano, Y. Kojima, K. Miyahara, J. Onoda, H. Yokoi, and K. Ikeda. 2010. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma. Int. Arch. Allergy Immunol. 151:8-16.
50. Rafei, M., E. Birman, K. Forner, and J. Galipeau. 2009. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol. Ther. 17:1799-1803.
51. Caligiuri, G., M. Rudling, V. Ollivier, M. P. Jacob, J. B. Michel, G. K. Hansson, and A. Nicoletti. 2003. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol. Med. 9:10-17.
52. Mallat, Z., S. Besnard, M. Duriez, V. Deleuze, F. Emmanuel, M. F. Bureau, F. Soubrier, B. Esposito, H. Duez, C. Fievet, et al. 1999. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85: e17-e24.
53. Pinderski Oslund, L. J., C. C. Hedrick, T. Olvera, A. Hagenbaugh, M. Territo, J. A. Berliner, and A. I. Fyfe. 1999. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 19:2847-2853.
54. -/- mice. FASEB J. 15:2730-2732.
55. Pinderski, L. J., M. P. Fischbein, G. Subbanagounder, M. C. Fishbein, N. Kubo, H. Cheroutre, L. K. Curtiss, J. A. Berliner, and W. A. Boisvert. 2002. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ. Res. 90:1064-1071.
56. O'Shea, J. J., and P. J. Murray. 2008. Cytokine signaling modules in inflammatory responses. Immunity 28:477-487.
57. Dansky, H. M., S. A. Charlton, M. M. Harper, and J. D. Smith. 1997. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 94:4642-4646.
58. -/- mice. J. Clin. Invest. 100:1575-1580.
59. Buono, C., C. E. Come, G. Stavrakis, G. F. Maguire, P. W. Connelly, and A. H. Lichtman. 2003. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 23:454-460.
60. Gupta, S., A. M. Pablo, X. Jiang, N. Wang, A. R. Tall, and C. Schindler. 1997. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99:2752-2761.
61. -/- mice. J. Interferon Cytokine Res. 22:661-670.
62. -/- mice. Am. J. Pathol. 157:1819-1824.
63. Chen, S., T. R. Crother, and M. Arditi. 2010. Emerging role of IL-17 in atherosclerosis. J. Innate Immun. 2:325-333.
64. Martin-Orozco, N., Y. Chung, S. H. Chang, Y. H. Wang, and C. Dong. 2009. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 39:216-224.
65. Bending, D., H. De La Pena, M. Veldhoen, J. M. Phillips, C. Uyttenhove, B. Stockinger, and A. Cooke. 2009. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. pii: 37865.
66. Lee, Y. K., H. Turner, C. L. Maynard, J. R. Oliver, D. Chen, C. O. Elson, and C. T. Weaver. 2009. Late developmental plasticity in the T helper 17 lineage. Immunity 30:92-107.
67. O'Connor, R. A., C. T. Prendergast, C. A. Sabatos, C. W. Lau, M. D. Leech, D. C. Wraith, and S. M. Anderton. 2008. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 181:3750-3754.
68. de Boer, O. J., J. J. van der Meer, P. Teeling, C. M. van der Loos, M. M. Idu, F. van Maldegem, J. Aten, and A. C. van der Wal. 2010. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J. Pathol. 220:499-508.